Long-Term Assets: The sum of all assets classified as non-current.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Long-Term Assets of $0.45M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$1.80M |
|
$-11.76M |
|
-- |
|
$1.80M |
|
$13.25M |
|
$-11.45M |
|
$-0.31M |
|
$-11.76M |
|
$-11.76M |
|
$-11.76M |
|
$-11.76M |
|
$-11.76M |
|
$-11.76M |
|
$-11.45M |
|
$-11.11M |
|
0.62M |
|
0.62M |
|
$-18.71 |
|
$-18.71 |
|
| Balance Sheet Financials | |
$4.72M |
|
$0.03M |
|
|
Long-Term Assets |
$0.45M |
$5.17M |
|
$3.22M |
|
-- |
|
$0.67M |
|
$3.89M |
|
$1.28M |
|
$1.28M |
|
$1.28M |
|
0.79M |
|
| Cash Flow Statement Financials | |
$-8.90M |
|
$-0.01M |
|
$5.86M |
|
$7.75M |
|
$4.31M |
|
$-3.44M |
|
$2.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-637.42% |
|
-637.42% |
|
-618.45% |
|
-654.47% |
|
-654.47% |
|
$-8.91M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
-- |
|
14.62 |
|
24.97 |
|
-921.57% |
|
-921.57% |
|
-227.41% |
|
-921.57% |
|
$1.61 |
|
$-14.39 |
|
$-14.38 |
|